Healthscore 588·6 metrosupdated 2h ago
FDA's Review of Abortion Pill Mifepristone Frustrates Anti-Abortion Advocates
The FDA's ongoing safety review of mifepristone, the main abortion pill, will extend into next year, frustrating anti-abortion groups. The review follows a court order and is part of a broader push by some lawmakers to restrict the drug's use.
Where it's breaking
Local coverage
FDA says its safety review of abortion pill will continue into next year
FDA's ongoing review of abortion pill frustrates anti-abortion advocates
FDA's ongoing review of abortion pill frustrates anti-abortion advocates
Anti-Abortion Activists Push for Stricter Pill Regulations Amid Federal Review
Abortion foes plan to push pill restrictions in the states
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.